Accéder au contenu
Merck

Principaux documents

Voir toute la documentation

524636

Phosphatase Inhibitor Cocktail II

lyophilized solid, for the inhibition of acid and alkaline phosphatases and protein tyrosine phosphatases, This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

Synonyme(s) :

Inhibitor Cocktail

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Changer de vue

A propos de cet article

UNSPSC Code:
12352200
NACRES:
NA.54
Form:
solid
Solubility:
water: soluble
Storage temp.:
2-8°C
Service technique
Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.
Laissez-nous vous aider

Nom du produit

Phosphatase Inhibitor Cocktail Set II, Lyophilized, The Phosphatase Inhibitor Cocktail Set II, Lyophilized controls the activity of Phosphatase. This small molecule/inhibitor is primarily used for Phosphorylation & Dephosphorylation applications.

Quality Level

100

form

solid

manufacturer/tradename

Calbiochem®

storage condition

OK to freeze, desiccated (hygroscopic), protect from light

solubility

water: soluble

shipped in

ambient

storage temp.

2-8°C

General description

A cocktail of five phosphatase inhibitors for the inhibition of acid and alkaline phosphatases as well as protein tyrosine phosphatases (PTPs). Suitable for use with cell lysates and tissue extracts, including samples containing detergents. Provided as a set of five vials. Each vial, when reconstituted with 1 ml H2O, contains Imidazole (200 mM), Sodium Fluoride (100 mM), Sodium Molybdate (115 mM), activated Sodium Orthovanadate (100 mM), and Sodium Tartrate Dihydrate (400 mM). Reconstitute each vial with 1 ml H2O.

Packaging

Packaged under inert gas

Preparation Note

Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. Dilute 1:100 just prior to use.
Reconstitute each vial with 1 ml H₂O.

Other Notes

Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.

Legal Information

CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Toxicity: Toxic (F)

Still not finding the right product?

Explore all of our products under

signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Repr. 1B - Skin Corr. 1C

Classe de stockage

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

Certificats d'analyse (COA)

Recherchez un Certificats d'analyse (COA) en saisissant le numéro de lot du produit. Les numéros de lot figurent sur l'étiquette du produit après les mots "Lot" ou "Batch".

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Jrhau Lung et al.
American journal of translational research, 13(10), 11194-11208 (2021-11-18)
Cullin 4A (Cul4A) reportedly has oncogenic roles in several cancer types by regulating tumor suppressors through the ubiquitination and proteolysis of the tumor suppressor. In addition, Cul4A is associated with chemosensitivity to chemotherapy drugs. This study investigated the association between
Delphine Séhédic et al.
Frontiers in bioengineering and biotechnology, 8, 602998-602998 (2021-03-16)
Inhibition of the PI3K/Akt/mTOR signaling pathway represents a potential issue for the treatment of cancer, including glioblastoma. As such, rapamycin that inhibits the mechanistic target of rapamycin (mTOR), the downstream effector of this signaling pathway, is of great interest. However
Zeda Zhang et al.
Cancer cell, 38(2), 279-296 (2020-07-18)
Despite the development of second-generation antiandrogens, acquired resistance to hormone therapy remains a major challenge in treating advanced prostate cancer. We find that cancer-associated fibroblasts (CAFs) can promote antiandrogen resistance in mouse models and in prostate organoid cultures. We identify
Afficher tous les articles scientifiques apparentés